Unverified50% confidenceFactExact time
The U.S. FDA has begun requiring AI-assisted diagnostic systems to have explicit uncertainty indication features.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
9/1/2026
First Seen
Valid until: 11/30/2026
Sources
Related Entities
Related Claims
VerifiedThe EU AI Act classifies medical auxiliary diagnosis systems as high-risk AI systems and requires verifiable decision-making rationale to be provided.77% similarUnverifiedThe 2023 Biden administration AI Executive Order requires frontier AI systems to undergo dual-use biotechnology safety testing before release.74% similarUnverifiedRegulatory bodies including the U.S. National Highway Traffic Safety Administration (NHTSA), the EU AI Act, and China's Ministry of Industry and Information Technology have begun requiring a certain degree of interpretability or auditability for high-risk AI systems.72% similarUnverified医疗AI临床落地需要通过随机对照试验验证，FDA对SaMD有专门监管框架，欧盟AI法案将医疗AI列为高风险类别71% similarVerifiedThe U.S. White House's AI executive order requires frontier models to undergo safety evaluations before release.67% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/839168API
curl https://kongchang.com/api/v1/knowledge/claims/839168MCP
get_claim(id=839168)